Drug Master Files Guidance for Industry

This guidance provides FDA’s current thinking on drug master files (DMFs), which are 17 submissions to FDA that may be used to provide confidential, detailed information about 18 facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of 19 human drug products.

Partager l’article